Marit Rønning
Impact in
-
- Antibiotic Use and Resistance
- Geriatrics and Gerontology top 10%
Papers in
-
- Antibiotic Use and Resistance 6
-
- Pharmaceutical Practices and Patient Outcomes 2
- Co-authors
- Kari Furu (4 shared papers)Svetlana Ondrasova Skurtveit (5 shared papers)Anders Engeland (4 shared papers)Hege Salvesen Blix (7 shared papers)Anne Kjersti Daltveit (1 shared paper)Jørgen G. Bramness (2 shared papers)Hanne Strøm (3 shared papers)Solveig Sakshaug (4 shared papers)
In The Last Decade
Marit Rønning
19 papers receiving 779 citations
Peers
Comparison fields: 5 of 80
- Applied Microbiology and Biotechnology 174
- Geriatrics and Gerontology 24
- Neurology 86
- Public Health, Environmental and Occupational Health 146
- Pediatrics, Perinatology and Child Health 90
Countries citing papers authored by Marit Rønning
This map shows the geographic impact of Marit Rønning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Rønning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Rønning more than expected).
Fields of papers citing papers by Marit Rønning
This network shows the impact of papers produced by Marit Rønning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Rønning. The network helps show where Marit Rønning may publish in the future.
Co-authors
The 25 scholars most cited alongside Marit Rønning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 160 | |
| 2 | 2013 | 124 | |
| 3 | 2000 | 82 | |
| 4 | 2007 | 76 | |
| 5 | 1999 | 63 | |
| 6 | 2011 | 59 | |
| 7 | 2007 | 56 | |
| 8 | 2010 | 53 | |
| 9 | 2011 | 33 | |
| 10 | 2003 | 32 | |
| 11 | EURO-MED-STAT - Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach | 2003 | 18 |
| 12 | 2009 | 15 | |
| 13 | Drug Utilization Research | 2008 | 15 |
| 14 | 2011 | 14 | |
| 15 | 2010 | 4 | |
| 16 | 2022 | 2 | |
| 17 | Hvor mange og hvem behandles medikamentelt for diabetes mellitus | 2006 | 1 |
| 18 | Antibiotikaforbruk i Norge | 2008 | 1 |
| 19 | 2024 | 1 | |
| 20 | Forskrivning av selektive serotoninreopptakshemmere 1990 – 2004 | 2005 | 1 |
About Marit Rønning
Marit Rønning is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Psychiatry and Mental health, Economics and Econometrics and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 810 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (6 papers), Pharmaceutical Economics and Policy (3 papers), Pneumonia and Respiratory Infections (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Diet and metabolism studies (1 paper), Schizophrenia research and treatment (1 paper), Pregnancy and Medication Impact (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (174 citations), Geriatrics and Gerontology (24 citations), Neurology (86 citations), Public Health, Environmental and Occupational Health (146 citations) and Pediatrics, Perinatology and Child Health (90 citations). Marit Rønning has collaborated with scholars based in Norway, Sweden and Spain. Frequent co-authors include Kari Furu, Svetlana Ondrasova Skurtveit, Anders Engeland, Hege Salvesen Blix, Anne Kjersti Daltveit, Jørgen G. Bramness, Hanne Strøm, Solveig Sakshaug, Øystein Karlstad and Christina Greko. Their work appears in journals such as European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, BMC Family Practice, Journal of Antimicrobial Chemotherapy and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.